Latest News

Latest News

News from the World Hepatitis Alliance

New addition to the WHA team

28 Jan 2016 Bridie Taylor

Preparations for the second World Hepatitis Summit (WHS2017), taking place in Brazil early 2017, are now underway and the World Hepatitis Alliance...

WHA presents Tools For Change webinar series to enhance patient advocacy

27 Jan 2016 Bridie Taylor

Patient group advocacy has the power to effect real lasting change and improve the lives of millions living with viral hepatitis. We believe that...

Welcoming five new members to the World Hepatitis Alliance

26 Jan 2016 Bridie Taylor

This month, we welcome five new organisations to the World Hepatitis Alliance. Our alliance is now made up of 230 organisations in 81 countries in...

Hepatitis Testing Innovation Contest now open for submissions!

19 Jan 2016 Tara Farrell

Do you have a new and exciting idea on how to deliver hepatitis B and C testing? Be in with a chance to contribute to the 2016 WHO Hepatitis Testing...

World Hepatitis Day 2015 Summary Report released

19 Jan 2016 Bridie Taylor

On 28 July, World Hepatitis Day (WHD) brings the world together to raise awareness of the global burden of viral hepatitis and to influence real...

Public health experts, patients and policymakers convene at inaugural African Viral Hepatitis Summit to discuss the need for comprehensive national plans

19 Jan 2016 Tara Farrell

Today, more than 100 leading African and international public health experts, patient representatives, policymakers and physicians have gathered in...

Patient Solidarity Day: Uniting to declare healthcare a human right

3 Dec 2015 Bridie Taylor

On 5th December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that healthcare is a human right. Co-ordinated by...

Welcoming four new members

2 Dec 2015 Bridie Taylor

The World Hepatitis Alliance continues to grow as we welcome four new member organisations. Our membership is now made up of over 225 groups in 81...

HIV patients with viral hepatitis are three times more likely to have liver disease, liver failure and liver-related deaths

1 Dec 2015 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2015 -...

Innovative patent agreement shows success of patient advocacy

23 Nov 2015 Bridie Taylor

The World Hepatitis Alliance congratulates the Medicines Patent Pool (MPP) and Bristol – Myers Squibb (BMS) for recognising the global hepatitis...

Medicines Patent Pool expands its mandate to hepatitis C treatment

6 Nov 2015 Bridie Taylor

The World Hepatitis Alliance welcomes the recent announcement from the Medicines Patent Pool (MPP) that they will be expanding their mandate to...

The global hepatitis community unites to demand access to life-saving hepatitis treatment

2 Nov 2015 Bridie Taylor

London, 2 November 2015: Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-...

Webinar on the Global Movement to Eliminate Viral Hepatitis

27 Oct 2015 Bridie Taylor

Learn more about the global movement to eliminate viral hepatitis. On 28 th October WHA President Charles Gore and WHA Executive Board Member for the...

WHO Regional Committee meetings see regions commit to tackling viral hepatitis

23 Oct 2015 Bridie Taylor

Despite viral hepatitis impacting almost every country in the world, the burden differs significantly from region to region. In order to achieve...

Expanding the membership base of the World Hepatitis Alliance

1 Oct 2015 Bridie Taylor

The membership base of the World Hepatitis Alliance continues to go from strength to strength as we welcome five new organisations. Our membership is...

Looking ahead to the next Summit

17 Sep 2015 Bridie Taylor

Following the first World Hepatitis Summit that took place in Glasgow, Scotland 2-4 September, we are already looking ahead to the next Summit. The...

Cost of comprehensive global viral hepatitis prevention and treatment effort might peak at $11 billion in 2025

15 Sep 2015

By Keith Alcorn, Infohep.org Reaching the World Health Organization’s proposed targets for viral hepatitis control by 2030 could require global...

Medicines Patent Pool looks at hepatitis C

14 Sep 2015

By Keith Alcorn, Infohep.org Greg Perry, Executive Director of the Medicines Patent Pool, told delegates at the World Hepatitis Summit in Glasgow...

World Health Organization calls for ambitious global targets for viral hepatitis control

5 Sep 2015

By Keith Alcorn, Infohep.org The World Health Organization (WHO) is calling for ambitious new global targets for diagnosis, treatment and cure of...

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit

4 Sep 2015 Bridie Taylor

New declaration on viral hepatitis, by leaders from 98 countries, sets targets to eliminate hepatitis at first ever world summit Global leaders...

Pages

News from infohep

Emricasan and selonsertib fail to improve fibrosis in people with NASH

12 Nov 2019 Liz Highleyman
A pair of experimental therapies for non-alcoholic steatohepatitis (NASH) failed to offer notable improvements in controlled clinical trials, despite...

When is the right time to treat hepatitis C in people with liver cancer?

27 Oct 2019 Keith Alcorn
Direct-acting antiviral treatment for hepatitis C need not be delayed until the completion of treatment for hepatocellular carcinoma (HCC; liver...

Tesamorelin reduces liver fat and fibrosis progression in people with HIV and NAFLD

21 Oct 2019 Keith Alcorn
Treatment with tesamorelin, a synthetic growth hormone-releasing hormone, reduced liver fat content and reduced the progression of liver fibrosis in...

Trivalent hepatitis B vaccine appears more effective than existing options

18 Oct 2019 Liz Highleyman
Sci-B-Vac, an investigational vaccine that contains three different hepatitis B virus (HBV) proteins, may offer more protection, especially for older...

Hepatitis C vaccine fails to prevent chronic infection

10 Oct 2019 Liz Highleyman
An experimental two-part vaccine was not able to prevent chronic hepatitis C virus (HCV) infection in a mid-stage study, according to a presentation...

People who use drugs would prefer to get hepatitis C treatment at a community pharmacy

4 Oct 2019 Keith Alcorn
Seventy-eight per cent of people using needle and syringe programmes in community pharmacies in London who opted to test for hepatitis C would prefer...

Non-alcoholic fatty liver disease raises the risk of cancer in overweight people

24 Sep 2019 Keith Alcorn
Obesity without non-alcoholic fatty liver disease (NAFLD) does not raise the risk of cancer, but people with NAFLD who are also obese are almost...

Fatty liver raises the risk of death in people with HIV and hepatitis C

15 Sep 2019 Keith Alcorn
People with HIV and hepatitis C co-infection who had fatty liver disease were twice as likely to die during a five-year follow-up period as their...

Does hepatitis C virus remain in the body after successful treatment?

11 Sep 2019 Keith Alcorn
Persistence of very low-level hepatitis C infection after a sustained virologic response to hepatitis C treatment is an extremely rare event and is...

Curing hepatitis C may reduce inflammation in people with HIV

11 Sep 2019 Liz Highleyman
Successful treatment of hepatitis C virus (HCV) may lead to a reduction in immune activation related to leakage of bacteria from the gut in people...